HK Stock Market Move | CSPC PHARMA (01093) fell more than 10% in the afternoon, with a 40% decrease in net profit in the first quarter compared to the same period last year and a 7.8% drop in revenue.

CSPC PHARMA (01093) saw a significant decline in its stock price in the afternoon, falling more than 10% at one point. As of the time of writing, it has fallen by 5.51%, closing at HK$7.03 with a turnover of HK$9.32 billion. On the news front, CSPC PHARMA released its financial results for the first quarter of 2026 on May 27th, with a revenue of RMB 6.465 billion, a decrease of 7.8% year-on-year. The net profit attributable to shareholders of the company was RMB 860 million, a decrease of 41.8% year-on-year. The announcement stated that the decrease in net profit was mainly due to the higher licensing fee income received in the same period last year. Excluding the impact of licensing fee income, the net profit attributable to shareholders of the company for this period was RMB 736 million, a decrease of 7.3% from the same period last year.